Crescent Biopharma CBIO
NASDAQ CBIO
$16.72 +0.49 (+2.99%)
As of: Aug 21, 2026 · 11:04 AM EDT

Crescent Biopharma (CBIO) EPS (Basic) Growth (3y) (2016 - 2026)

Crescent Biopharma (CBIO) EPS (Basic) Growth (3y) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 140.14 Bn 132.29 Bn 2.84 Bn 6.85%
2 Regeneron Pharmaceuticals 87.02 Bn 79.03 Bn 3.93 Bn 11.71%
3 Argenx Se 65.30 Bn 60.12 Bn 1.37 Bn 64.84%
4 Moderna 60.84 Bn 55.70 Bn 52.00 Mn 18.44%
5 BeOne Medicines 42.15 Bn 37.06 Bn 1.53 Bn 37.21%
6 Alnylam Pharmaceuticals 31.49 Bn 28.18 Bn 992.69 Mn 36.73%
7 BioNTech SE 28.78 Bn 10.38 Bn 668.28 Mn -26.87%
8 Insmed 27.55 Bn 26.39 Bn 358.27 Mn 67.51%
9 Royalty Pharma 27.14 Bn 26.31 Bn - -38.31%
10 Crescent Biopharma 1.07 Bn 897.86 Mn - -44.16%

Historic Data

Download Data
DateValue
Jun 30, 2026 35.59%
Mar 31, 2026 14.07%
Dec 31, 2025 12.88%
Sep 30, 2025 31.10%
Jun 30, 2025 22.21%
Mar 31, 2025 49.69%
Dec 31, 2024 6.46%
Sep 30, 2024 23.18%
Jun 30, 2024 17.56%
Mar 31, 2024 16.05%
Dec 31, 2023 25.05%
Sep 30, 2023 20.89%
Jun 30, 2023 26.33%
Mar 31, 2023 0.80%
Dec 31, 2022 16.95%
Sep 30, 2022 19.01%
Jun 30, 2022 28.26%
Mar 31, 2022 18.70%
Dec 31, 2021 46.32%
Sep 30, 2021 24.59%